Clinical trial
Safety and Efficacy of Photodynamic Therapy With Short Incubation Methylaminolevulinate Without Occlusion in the Treatment of Actinic Keratoses.
NCT00926952 is registered in ClinicalTrials.gov with Innovaderm Research Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Photodynamic Therapy With Short Incubation Methylaminolevulinate Without Occlusion in the Treatment of Actinic Keratoses.
- Lead sponsor
- Innovaderm Research Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- January 31, 2011
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
actinic keratosis